Laser

Cataract and glaucoma laser platform
Optimis Fusion is a versatile laser platform combining YAG photodisruption treatments and advanced SLT photoregeneration therapy in one fully integrated system.
Upgradable, it can easily be transformed into an anterior and posterior laser treatment platform by combing it with a compatible Quantel Medical retina laser.
Key features:
- Premium optics for viewing both the anterior and posterior segments.
- Quantel Medical proprietary technology: dual-mode YAG/SLT laser cavity.
Premium Optics
Built into a premium Zeiss type slit lamp Optimis Fusion provides a superior vision of both the anterior and posterior chambers.
It features a LED illumination source providing a sharp, bright and homogeneous illumination.
Advanced technology
Dual-mode YAG / SLT laser cavity, optimized to produce 1064nm and 532nm nanosecond pulses from one laser cavity.
Powerful, precise and efficient Nd:YAG Laser / Full-featured SLT laser
Easy switch from YAG to SLT mode, easy to use software
Advanced combination laser platform
Fully integrated glaucoma and cataract laser platform
Optimis Fusion easily combines with Quantel Medical Vitra 2 monospot or multispot photocoagulators, offering a YAG , SLT and Multispot Retina Laser platform all in one. More information
Precise & Powerful
Optimis Fusion YAG laser delivers high-performance photodisruption for capsulotomy and peripheral iridotomy. Its gaussian laser beam profile allows for precise delivery, only requiring minimum energy levels, which avoids side effects such as lens pitting.
Precise tissue targeting is achieved with the advanced two-point aiming beam, allowing for fast and accurate targeting of the capsule; and the adjustable offset feature, allowing for easy focus adjustment behind or at the point of disruption.

SLT laser therapy

First line treatment. No thermal Damage. Repeatable.
Selective Laser Trabeculoplasty (SLT) is a proven therapy supported by more than 10 years of clinical data. SLT targets melanin-rich cells which absorb the laser energy to induce a healing response that begins to restore the function of the trabecular meshwork.
The laser energy is delivered in short, fixed pulses over a large, homogeneous spot size, resulting in no thermal damage. Due to the gentle delivery and no permanent destruction to the trabecular meshwork, SLT leaves the structures intact and can be repeated if necessary.
Symposium
ESCRS 2022 - YAG Posterior Capsulotomy: The final hurdle to a Premium Visual Outcome
ESCRS 2022 - SLT as a first line treatment: Which patients are likely to benefit the most
ESCRS 2020 - Selective Laser Trabeculoplasty (SLT): A Clinically Proven First-Line Treatment
ESCRS 2020 - Where to rank laser in glaucoma treatment?
ESCRS 2019 - SLT: A clinically proven safe and effective first line treatment
PAAO 2019 - Trabeculoplastia selectiva laser
Interview
Introducing Optimis Fusion, a New SLT/YAG laser
Vitra 2

Retinal Photocoagulation
Multispot Laser Adaptator

Vitra 2 Laser adapator